Vor Biopharma Inc (VOR)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.19B
Last updated: Nov 17, 2026 at 4:15 PM ET
Vor Biopharma Inc (VOR) Statistics
Vor Biopharma (VOR) has a market cap of $1.19B and an enterprise value of $1.11B. Its share count is up 793.02% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 6.62% below the market cap, as cash exceeds debt.
| Market Cap | $1.19B |
|---|---|
| Enterprise Value | $1.11B |
| Latest price (Nov 17, 2026) | $18.18 |
Key Dates
The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 29, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 30, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is up 81.62% over 52 weeks and trades 7.86% below its 50-day average.
| Beta (1Y) | 1.62 |
|---|---|
| 52-Week Change | +81.62% |
| 1-Month Change | +0.78% |
| 3-Month Change | -22.90% |
| 6-Month Change | +28.66% |
| 5-Year Change | -93.74% |
| Total Return (1Y) | +81.62% |
| Total Return (3Y CAGR) | -19.76% |
| Total Return (5Y CAGR) | -42.18% |
| Return vs SPY (1Y) | +87.78% |
| Max Drawdown (1Y) | -33.41% |
| Max Drawdown (3Y) | -94.69% |
| Sharpe Ratio (1Y) | 0.76 |
| Correlation with SPY (1Y) | 0.25 |
| 50-Day Average | $19.73 |
| 200-Day Average | $17.59 |
| 52-Week Range | $6.50 to $26.00 |
| RSI (14 Days) | 41.7 |
| Average Volume (20 Days) | 720.87K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 13.50x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 13.50x |
|---|---|
| Quick Ratio | 13.50x |
| Debt / Equity | 0.00x |
Returns and Efficiency
| Return on Assets (ROA) | 272.76% |
|---|---|
| ROA (5Y Average) | -70.09% |
| ROIC (5Y Average) | 337.44% |
Scores
VOR has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$23.00K |
| Operating Income | -$177.42M |
| Pretax Income | $1.35B |
| Net Income | $1.35B |
| Reported EPS (TTM) | $305.10 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $78.98M |
|---|---|
| Total Debt | $0 |
| Net Cash | $78.98M |
| Net Cash Per Share | $1.32 |
| Working Capital | $454.18M |
| Shareholder Equity | -$137.17M |
| Total Assets | $496.31M |
| Total Liabilities | $633.49M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $507.00K of capital spending, operating cash flow left -$119.68M of free cash flow.
| Operating Cash Flow | -$119.17M |
|---|---|
| Capital Expenditures | $507.00K |
| Free Cash Flow | -$119.68M |
| FCF Per Share | -$2.02 |
| Depreciation and Amortization | $1.54M |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
VOR does not pay a dividend. Its free cash flow yield is -11.03%.
| FCF Yield | -11.03% |
|---|---|
| Buyback Yield | -39.79% |
| Shareholder Yield | -39.79% |
Stock Splits
The last split was a 1-for-20 reverse split on Sep 19, 2025.
| Last Split Date | Sep 19, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:20 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About VOR
What is VOR's market cap?
Vor Biopharma has a market cap of $1.19B. Its enterprise value, which adds debt and subtracts cash, is $1.11B.
How many shares of VOR are outstanding?
Vor Biopharma has 59.67M shares outstanding. The count is up 793.02% from a year earlier.
Does VOR pay a dividend?
No. Vor Biopharma does not pay a dividend.
How much debt does VOR have?
Vor Biopharma has $0 of total debt and $78.98M of cash and equivalents, a net cash position of $78.98M.
VOR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors